OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 82 filers reported holding OVID THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,000 | 0.0% | 1,532 | -2.3% | 0.00% | – |
Q2 2022 | $3,000 | -70.0% | 1,568 | -48.9% | 0.00% | – |
Q1 2022 | $10,000 | -75.6% | 3,068 | -76.2% | 0.00% | – |
Q4 2021 | $41,000 | -77.5% | 12,906 | -76.2% | 0.00% | – |
Q3 2021 | $182,000 | -29.2% | 54,307 | -17.3% | 0.00% | – |
Q2 2021 | $257,000 | -61.6% | 65,701 | -60.5% | 0.00% | -100.0% |
Q1 2021 | $669,000 | +340.1% | 166,356 | +153.5% | 0.00% | – |
Q4 2020 | $152,000 | – | 65,635 | +105762.9% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 62 | -99.3% | 0.00% | – |
Q2 2020 | $62,000 | – | 8,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |